Quantcast

Tag Archives: generic drug litigation

Generic drug maker faces liability for out-of-date warning label

Federal law does not preempt a product liability suit alleging that the maker of a generic form of Fosamax failed to update its warning label in conformity with revised brand-name warnings, the California Court of Appeal has ruled in affirming ...

Read More »

Ruling may save suits against generic drug makers

Since last year, when generic drug makers won a victory on the issue of federal preemption before the U.S. Supreme Court, lower courts have been dismissing cases against generic drug makers left and right. But last week a federal appeals ...

Read More »